======= PMP22 ======= == Gene Information == * **Official Symbol**: PMP22 * **Official Name**: peripheral myelin protein 22 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5376|5376]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q01453|Q01453]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PMP22&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PMP22|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601097|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an integral membrane protein that is a major component of myelin in the peripheral nervous system. Studies suggest two alternately used promoters drive tissue-specific expression. Various mutations of this gene are causes of Charcot-Marie-Tooth disease Type IA, Dejerine-Sottas syndrome, and hereditary neuropathy with liability to pressure palsies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]. * **UniProt Summary**: Might be involved in growth regulation, and in myelinization in the peripheral nervous system. |PMP22 Claudin| |compact myelin| |bleb assembly| |myelin assembly| |peripheral nervous system development| |cellular component assembly involved in morphogenesis| |myelination| |axon ensheathment| |ensheathment of neurons| |bicellular tight junction| |negative regulation of neuron projection development| |negative regulation of cell projection organization| |negative regulation of neuron differentiation| |negative regulation of neurogenesis| |negative regulation of nervous system development| |negative regulation of cell development| |anterograde trans-synaptic signaling| |chemical synaptic transmission| |trans-synaptic signaling| |plasma membrane bounded cell projection assembly| |cell projection assembly| |synaptic signaling| |regulation of neuron projection development| |regulation of neuron differentiation| |negative regulation of cell population proliferation| |regulation of plasma membrane bounded cell projection organization| |negative regulation of cellular component organization| |regulation of cell projection organization| |negative regulation of cell differentiation| |regulation of neurogenesis| |cellular component morphogenesis| |anatomical structure formation involved in morphogenesis| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |cell death| |cell-cell signaling| |plasma membrane bounded cell projection organization| |cell projection organization| |negative regulation of multicellular organismal process| |generation of neurons| |regulation of cell population proliferation| |neurogenesis| |regulation of cell differentiation| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-1.97| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|-1.9| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|1.79| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|1.81| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|2.79| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18160 * **Expression level (log2 read counts)**: 4.11 {{:chemogenomics:nalm6 dist.png?nolink |}}